Pathogenic germline variants (PGVs) in one of the known high-risk breast cancer susceptibility genes e.g. BRCA1, BRCA2, PALB2 confer a high risk of developing breast cancer and are enriched in familial cases. The gene discussed is BRCA2; the disease is breast cancer.